PALATIN TECHNOLOGIES, INC. Finance Lease, Right-of-Use Asset, Amortization
PALATIN TECHNOLOGIES, INC. (PTN) reported Finance Lease, Right-of-Use Asset, Amortization of $45.97 thousand for the 12-month period ending 2025-06-30, per its 10-K filed 2025-09-23.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2025-09-23
- PALATIN TECHNOLOGIES, INC. finance lease, right-of-use asset, amortization for fiscal 2025 was $45.97K, a 56.79% decline from fiscal 2024.
- PALATIN TECHNOLOGIES, INC. finance lease, right-of-use asset, amortization for fiscal 2024 was $106.39K, a 5.42% increase from fiscal 2023.
- PALATIN TECHNOLOGIES, INC. finance lease, right-of-use asset, amortization for fiscal 2023 was $100.92K, a 78.74% increase from fiscal 2022.
- PALATIN TECHNOLOGIES, INC. finance lease, right-of-use asset, amortization for fiscal 2022 was $56.46K.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|
| 2025-06-30 | $45.97K 10-K · filed 2025-09-23 |
| 2024-06-30 | $106.39K 10-K · filed 2025-09-23 |
| 2023-06-30 | $100.92K 10-K · filed 2024-09-30 |
| 2022-06-30 | $56.46K 10-K · filed 2023-09-28 |
| 2021-06-30 | $0.00 10-K · filed 2022-09-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |